News

Mechanistic discrepancies between species highlights the limitations of mouse models in advancing STING inhibition drugs for various diseases.
The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple ...
Preclinical study results provide a comprehensive transcriptomic characterization of regenerative wound repair in the oral ...
The Hopewell site is equipped to support clinical-stage development, process-development, and scaleup for cell and gene therapy programs.
The acquisition of Serva Electrophoresis by LICORbio is effective immediately, with integration activities already underway.
Building blocks for flexible bioprocessing must also be easy to install and take little time to train operators.
Drug industry regulators are embracing AI to streamline their oversight activities, but the plan for how they will do this is ...
There's overwhelming similarities between the EU and the U.S. in terms of advanced therapy medicinal products, but there are also nuances ...
Integrating cell-free protein synthesis and vesicle-based delivery enhances membrane proteins’ stability and functionality.
Experimental myosin inhibitor MT-125 sensitizes glioblastoma to radiation and kinase inhibitors, prolonging survival in mouse models.
Recent technological advancements have made recovery from paralysis a real possibility for the first time in history.
The study suggests that targeted brain stimulation could help bridge this gap. Academic learning has profound implications ...